Moderna began trials of a vaccine from Omicron
Moderna announced that it has begun testing a booster dose of its COVID-19 vaccine specifically designed to fight the Omicron strain.
Read MoreModerna announced that it has begun testing a booster dose of its COVID-19 vaccine specifically designed to fight the Omicron strain.
Read MoreDr. Catherine Poling, an infectious disease specialist, member of the Advisory Committee on Immunization Practices and a vaccinologist at Atrium Health Wake Forest Baptist in North Carolina
Read MorePfizer’s vaccine adapted to the Omicron coronavirus strain will be ready in March 2022. Pfizer CEO Albert Burla announced this on Monday.
Read MorePeople who test positive for COVID-19 only need isolation for 5 days until symptoms disappear, the U.S. Centers for Disease Control and Prevention (CDC) has officially announced.
Read MoreThe U.S. federal government is ready to provide additional support to state authorities in light of the spread of the Omicron strain in the country.
Read MoreEuropean medical experts are holding their breath – the coming weeks will be decisive for the continent.
Read MoreThe “Omicron”-strain of the coronavirus has even reached the White House, U.S. President Joe Biden said.
Read MoreResearchers from ZOE, the British company that created the ZOE COVID Study apps to track COVID-19, compared symptoms of thousands of people who were diagnosed with the coronavirus in October, when the delta variant dominated London, and in December, when the omicron strain supplanted it
Read MoreModerna has provided an update on the 50-microgram booster dose of its vaccine, which says it increases antibodies against the omicron strain of coronavirus by 37 times.
Read MoreThe first cases of infection with the Omicron strain of the coronavirus have been identified in Washington, D.C., the D.C. Department of Health said.
Read More